首页> 外文期刊>Liver international : >Presumed missense and synonymous mutations in ATP ATP 7B gene cause exon skipping in Wilson disease
【24h】

Presumed missense and synonymous mutations in ATP ATP 7B gene cause exon skipping in Wilson disease

机译:ATP ATP 7B基因的假定畸形和同义突变导致威尔逊病的外显子跳过

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Background & Aims Wilson disease is an inborn error of metabolism caused by abnormalities of the copper‐transporting protein‐encoding gene ATP 7B . Recently, the phenomenon of exon skipping, in which exonic mutations result in abnormal splicing, has been associated with various diseases. The present study investigated the splicing defects of the ATP 7B exonic variants identified in a cohort of 44 patients with Wilson disease. Method All patients were analysed for ATP 7B gene by direct sequencing or multiplex ligation‐dependent probe amplification analysis. To identify the potential pathogenicity of the candidate mutations that may induce exon skipping, both in vivo RT ‐ PCR analysis using RNA from peripheral leukocytes and in vitro functional splicing by minigene construction were conducted. Results The patterns of inheritance of the mutations in ATP 7B identified in 44 patients exhibited homozygotes (7 patients), compound heterozygotes (32 patients) and heterozygotes (5 patients). In all patients, we detected 25 different ATP 7B mutations, including 17 missenses, 1 frameshift, 3 nonsenses, 2 exonic deletions and 2 splicing alteration. In these mutations, 4 mutations have not been previously described in the literature or entered in human genome mutation database. Furthermore, we identified synonymous mutation c.4014TA and missense mutation R919G caused exon skipping in the ATP 7B mRNA transcript. Conclusion Our results suggest that aberrant exon skipping associated to putative splicing enhancer disruption and silencer creation is one previously unrecognized mechanism in Wilson disease. What is more, the multiplex ligation‐dependent probe amplification assay for the detection of exon deletions may be valuable in individuals with clinical Wilson disease diagnosis where one or no mutation has been identified by sequencing.
机译:None

著录项

  • 来源
    《Liver international :》 |2018年第8期|共10页
  • 作者单位

    Nanjing Key Laboratory of PediatricsChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Nanjing Key Laboratory of PediatricsChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Department of GastroenterologyChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Department of GastroenterologyChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Department of GastroenterologyChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Nanjing Key Laboratory of PediatricsChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Nanjing Key Laboratory of PediatricsChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Department of GastroenterologyChildren's Hospital of Nanjing Medical UniversityNanjing China;

    Nanjing Key Laboratory of PediatricsChildren's Hospital of Nanjing Medical UniversityNanjing China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 内科学;
  • 关键词

    ATP 7B gene; exonic splicing enhancer; exonic splicing silencer; Wilson disease;

    机译:ATP 7B基因;封锁拼接增强剂;封面拼接消音器;威尔逊病;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号